These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
310 related items for PubMed ID: 37219996
1. Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel. Hershko Y, Adler A. Microb Drug Resist; 2023 Jul; 29(7):302-308. PubMed ID: 37219996 [Abstract] [Full Text] [Related]
2. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract. He G, Wu L, Zheng Q, Jiang X. Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867 [Abstract] [Full Text] [Related]
3. [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria]. Özkarataş MH, Arslan N, Esen N, Özkütük AA. Mikrobiyol Bul; 2023 Apr; 57(2):220-237. PubMed ID: 37067207 [Abstract] [Full Text] [Related]
4. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran. Heidarieh P, Mirsaeidi M, Hashemzadeh M, Feizabadi MM, Bostanabad SZ, Nobar MG, Hashemi Shahraki A. Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990 [Abstract] [Full Text] [Related]
5. Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution. Fröberg G, Maurer FP, Chryssanthou E, Fernström L, Benmansour H, Boarbi S, Mengshoel AT, Keller PM, Viveiros M, Machado D, Fitzgibbon MM, Mok S, Werngren J, Cirillo DM, Alcaide F, Hyyryläinen HL, Aubry A, Andres S, Nadarajan D, Svensson E, Turnidge J, Giske CG, Kahlmeter G, Cambau E, van Ingen J, Schön T, EUCAST AMST and ESCMYC study groups. Clin Microbiol Infect; 2023 Jun; 29(6):758-764. PubMed ID: 36813087 [Abstract] [Full Text] [Related]
6. Epidemiology of Nontuberculous Mycobacteria in Tuberculosis suspects, Southwest of China, 2017-2022. Wang DM, Liu H, Zheng YL, Xu YH, Liao Y. Front Cell Infect Microbiol; 2023 Jun; 13():1282902. PubMed ID: 38029240 [Abstract] [Full Text] [Related]
7. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan. Hatakeyama S, Ohama Y, Okazaki M, Nukui Y, Moriya K. BMC Infect Dis; 2017 Mar 07; 17(1):197. PubMed ID: 28270102 [Abstract] [Full Text] [Related]
8. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece. Gitti Z, Mantadakis E, Maraki S, Samonis G. Future Microbiol; 2011 Sep 07; 6(9):1099-109. PubMed ID: 21958147 [Abstract] [Full Text] [Related]
9. Cumulative antimicrobial susceptibilities for respiratory clinical isolates of Mycobacterium avium Complex, Mycobacterium kansasii, and Mycobacterium abscessus from Pakistan 2018 to 2022. Shakoor S, Shafiq S, Shahid A, Mir F, Ali R, Hasan R. Int J Mycobacteriol; 2023 Sep 07; 12(3):310-315. PubMed ID: 37721238 [Abstract] [Full Text] [Related]
10. Drug susceptibiity testing of nontuberculous mycobacteria by broth microdilution method. Sharma M, Malhotra B, Khandelwal S. Indian J Med Microbiol; 2021 Jul 07; 39(3):306-310. PubMed ID: 33846029 [Abstract] [Full Text] [Related]
11. Incidence, Clinical Manifestation, Treatment Outcome, and Drug Susceptibility Pattern of Nontuberculous Mycobacteria in HIV Patients in Tehran, Iran. Feysia SG, Hasan-Nejad M, Amini S, Hamzelou G, Kazemian H, Kardan-Yamchi J, Karami-Zarandi M, Feizabadi MM. Ethiop J Health Sci; 2020 Jan 07; 30(1):75-84. PubMed ID: 32116435 [Abstract] [Full Text] [Related]
12. In Vitro Susceptibility Testing of Eravacycline against Nontuberculous Mycobacteria. Brown-Elliott BA, Wallace RJ. Antimicrob Agents Chemother; 2022 Sep 20; 66(9):e0068922. PubMed ID: 35943269 [Abstract] [Full Text] [Related]
13. Identification of non-tuberculous mycobacteria isolated from clinical specimens at a tertiary care hospital: a cross-sectional study. Ahmed I, Jabeen K, Hasan R. BMC Infect Dis; 2013 Oct 22; 13():493. PubMed ID: 24148198 [Abstract] [Full Text] [Related]
14. Subspecies Distribution and Antimicrobial Susceptibility Testing of Mycobacterium abscessus Clinical Isolates in Madrid, Spain: a Retrospective Multicenter Study. Ruedas-López A, Tato M, Broncano-Lavado A, Esteban J, Ruiz-Serrano MJ, Sánchez-Cueto M, Toro C, Domingo D, Cacho J, Barrado L, López-Roa P. Microbiol Spectr; 2023 Jun 15; 11(3):e0504122. PubMed ID: 37212700 [Abstract] [Full Text] [Related]
15. [Frequently Isolated Slow Growing Nontuberculous Mycobacteria from Pulmonary Samples and Evaluation of Drug Susceptibility Testing Results in a Referral Hospital in Turkey]. Ceyhan İ, Özkara Ş, Güler MZ, Dulkar G, Altınsoy R, Vezir S. Mikrobiyol Bul; 2019 Jul 15; 53(3):330-335. PubMed ID: 31414634 [Abstract] [Full Text] [Related]
16. In Vitro Susceptibility Testing of a Novel Benzimidazole, SPR719, against Nontuberculous Mycobacteria. Brown-Elliott BA, Rubio A, Wallace RJ. Antimicrob Agents Chemother; 2018 Nov 15; 62(11):. PubMed ID: 30126964 [Abstract] [Full Text] [Related]
20. Skin and soft-tissue infections due to rapidly growing mycobacteria: An overview. Kumar C, Shrivastava K, Singh A, Chauhan V, Varma-Basil M. Int J Mycobacteriol; 2021 Nov 15; 10(3):293-300. PubMed ID: 34494569 [Abstract] [Full Text] [Related] Page: [Next] [New Search]